Direct comparison
Exclusive vs. Non-Exclusive License
Exclusive vs. non-exclusive license compared: rights granted, royalty rates, diligence obligations, best-fit technologies, and march-in-rights exposure.
Side-by-side comparison
| Dimension | Exclusive License | Non-Exclusive License |
|---|---|---|
| Number of licensees | One licensee only; institution typically also gives up its own commercial-use right (though research/education-use carve-outs are common) | Multiple licensees can hold rights to the same technology simultaneously |
| Typical royalty rate | Higher per-licensee rate; academic median around 3% of net sales per a 2023 PLOS ONE study, reported ranges roughly 1%-10%, directional only | Lower per-licensee rate, often offset by royalty income from multiple licensees |
| Diligence/milestone obligations | Typically heavy -- development plan, dated milestones, progress reports, minimum spending, remedy for missed milestones | Typically minimal or none, since the institution hasn't foreclosed licensing to a more active party |
| Best-fit technology | Early-stage, capital-intensive technology requiring years of investment (e.g. a drug candidate); the basis for a single spinout company | Broadly applicable technology used by many parties -- research tools, reagents, platform software, materials |
| Bayh-Dole march-in exposure | Applies -- 35 U.S.C. Section 203 lets the funding agency compel additional licensing under four narrow statutory conditions if the licensee fails to commercialize | Not a practical concern -- multiple licensees already using the technology inherently addresses the government's practical-application interest |
| Sublicensing | Common, but only if separately granted in the agreement -- not automatic | Less common; each party typically holds only its own direct license |
Common questions
FAQ
Can a license start non-exclusive and convert to exclusive later?+
Yes. Some agreements use an option or evaluation-license structure that converts to exclusive if the licensee meets defined conditions, such as a funding or development milestone. The reverse also happens: an exclusive license can convert to non-exclusive as the contractual remedy for a licensee that misses its diligence milestones.
Does an exclusive license always produce more total revenue for the institution?+
Not necessarily. An exclusive license typically commands a higher rate per licensee, but a non-exclusive strategy can generate comparable or greater aggregate royalty income across multiple licensees for a broadly applicable technology. The right structure depends on which approach actually gets the technology developed and used.
What is a sole license, and how is it different from an exclusive license?+
A sole license permits only one commercial licensee, like an exclusive license, but the institution retains its own right to practice the technology -- a right a true exclusive license typically forecloses.
